Good morning, folks, and apologies for the late start today. We were motoring along, but took a call from the Pharmalot brand director to talk about different ways to make this little site grow some more. Now, though, we have grabbed yet another cup of stimulation and returned to the pressing matters at hand. And there is lots to do. No need to dawdle, of course. Here are some items of interest. Stop back for updates and, meanwhile, have a great day...
Glaxo Doubts GLP-1 Diabetes Drugs Would Be OKed For Diabetes (Bloomberg News)
Teva And Galena Agree To Commercialization Deal (Dow Jones)
Merck Must Face Trial On Pregnancy Bias Claims (Courthouse News Service)
Drugmakers Nudged By FDA To Find Childhood Cancer Cures (Bloomberg News)
USP Unveils New Drug Naming Plan (InPharma Technologist)
Generic Drugmakers See A Drought Ahead (New York Times)
More Drug Use Cuts Medicare Costs, Says CBO (Pharma Times)
EDITOR'S NOTE: Please check this post for updates
1 Comment